nivolumab,ipilimumab,cabozantinib,sunitinib
exelixis,bms,pfizer
['gu ', 'kidney cancer', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'check,mate,9er', 'exelixis']
our cmo shares thoughts on the latest checkmate -9er results presented at #gu23 and our dedication to the #kidneycancer community. 
Biotechnology company striving to accelerate the development of new medicines for difficult-to-treat cancers. See our guidelines: https://t.co/eaLlId7wLk